Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: 180 Life Science, Argenx, Astrazeneca, Avillion, Bristol Myers Squibb, Cybin, FSD, Genentech, Iaso, Innovent, Janux, Lexicon, Novartis, Oncomatryx, Outlook, PDS, Priothera, Regeneron, Sanofi, Stealth, TG, Timber, Tscan, United, Y-mabs.